Beijing outpatient special-disease benefits for foreign residents

Confirm that the foreign participant has an active Beijing public-insurance record

A legally employed foreign national covered by China's foreign-employee social-insurance rules normally participates in Beijing employee basic medical insurance through the employer or work unit, subject to any applicable social-security agreement. The person must be actually enrolled and entitled; a work permit, residence permit, social-security card or old contribution statement alone does not prove that the current record is active. Ask the employer or Beijing medical-insurance service which document number, scheme and start date the system uses.

Beijing also publishes limited foreign-related resident-insurance routes. These include qualifying holders of a Foreign Permanent Resident ID Card who are not covered by another basic scheme, eligible spouses and minor children of Type A foreign work-permit holders, and foreign students through their schools. These categories do not mean that every foreign spouse, child, visitor or privately insured resident can enter Beijing resident insurance. The official English page's 2025 contribution amounts are historical; Beijing published separate 2026 amounts.

Before registration, compare the passport or permanent-resident identity number, name and date of birth in the insurance record with the hospital patient profile. Resolve replacement-passport, duplicate-profile or employer-reporting problems. A private, travel or international policy is a separate contract and does not create Beijing 门诊特殊病 recognition. Its pre-authorisation and claim requirements should be handled separately.

The operational test is active Beijing basic-medical-insurance participation, not nationality, residence alone or possession of a hospital card.

Use the current Beijing list of seventeen outpatient special diseases

The controlling Beijing registration form effective from 1 January 2026 lists seventeen local categories. Use the exact Chinese or official category, because some entries describe a treatment rather than every form of the underlying diagnosis. The 2026 rule also changes the asthma label from moderate-to-severe allergic asthma biologic treatment to moderate-to-severe asthma biologic treatment.

The current categories are listed below. This is the Beijing municipal benefit scope for registration, not a clinical checklist, not proof that a patient meets a category and not a national list. Another city may use a different label, disease set or recognition standard.

• Malignant-tumour outpatient treatment
• Multiple sclerosis
• Intraocular injection treatment for fundus disease
• Renal dialysis, including haemodialysis and peritoneal dialysis
• Haemophilia
• Aplastic anaemia
• Severe mental illness
• Pulmonary arterial hypertension targeted treatment
• Multidrug-resistant tuberculosis
• Niemann-Pick disease type C
• Moderate-to-severe asthma biologic treatment
• Idiopathic pulmonary fibrosis antifibrotic treatment
• Kidney-transplant anti-rejection treatment
• Combined liver-kidney-transplant anti-rejection treatment
• Liver-transplant anti-rejection treatment
• Heart-transplant anti-rejection treatment
• Lung-transplant anti-rejection treatment

Beijing has seventeen local registration categories. This does not mean all chronic diseases receive outpatient special-disease treatment.

Recognise that several Beijing categories are treatment-specific

A diagnosis such as asthma, a fundus condition, pulmonary fibrosis or pulmonary hypertension is not automatically equivalent to the Beijing benefit wording. The local categories refer to biologic treatment, intraocular injection, antifibrotic treatment or targeted treatment. Cancer is framed as malignant-tumour outpatient treatment, and transplant categories are framed around anti-rejection treatment. The authorised hospital must determine whether the medical evidence and planned treatment fit the current insurance category.

Beijing's public pages do not present one consolidated, current diagnostic-criteria manual for all seventeen categories. Do not invent laboratory thresholds, severity scores, medicine prerequisites or treatment periods. Ask the qualified hospital department and medical-insurance office which evidence applies to the exact category. The treating clinician decides diagnosis and treatment; insurance registration decides only whether the local administrative rule is met.

The 2020 addition rule confirms that only disease-related examination, treatment and medicine costs within the medical-insurance payment scope and limitations receive special-disease treatment. Having the category therefore does not make unrelated care or every prescribed item payable. If the hospital cannot explain why a service is excluded, request an item-level classification rather than assuming the diagnosis controls the whole invoice.

Complete local registration through an authorised Beijing hospital

Beijing's public workflow directs the participant to a hospital that can provide the relevant outpatient special-disease service. Bring the social-security card or medical-insurance code and the identity document linked to the record. Complete the application, obtain confirmation from the responsible clinician and have the hospital medical-insurance office complete registration or record filing. Ask which additional diagnosis certificate, record or examination evidence the category requires.

Treat clinician signature, hospital receipt and system activation as separate states. Ask when the registration becomes visible, which category and institution were recorded, and whether a paper or electronic confirmation is available. Beijing registration takes effect from the filing date, so costs before that date should not be assumed to receive retrospective special-disease payment. A diagnosis made earlier does not move the insurance effective date backward.

If the foreign participant cannot authenticate in the illustrated online channel, use the hospital or in-person route accepted for the linked identity document. Bring a Chinese interpreter if needed for clinical discussion, but do not ask a clerk to interpret medical risk. Keep copies of the application and evidence while preserving any originals needed for later cross-province or manual reimbursement use.

• Active Beijing employee or resident insurance
• Social-security card or medical-insurance code
• Linked identity document
• Current application and category-specific medical evidence
• Clinician confirmation
• Hospital medical-insurance office registration

Select two eligible institutions per disease, not any two hospitals

From 1 January 2023, an eligible Beijing participant may choose two outpatient special-disease institutions for each disease from the person's selected institutions or qualifying Class A, specialist, traditional-Chinese-medicine or community institutions. Each institution must actually provide the relevant special-disease service and complete the required registration. The rule does not guarantee that every Class A hospital treats every category or that every campus shares the same qualification.

Ask the hospital medical-insurance office to confirm the exact disease, institution code and campus. If two institutions are useful, consider the roles needed for clinical care and medicine supply, but let the treating team decide medical appropriateness. Appointment availability or a specialist referral does not automatically update the insurance selection. Check whether both institutions appear in the live record before using the second provider.

Care outside the selected record does not receive Beijing outpatient special-disease treatment merely because the hospital is generally designated. The 2020 rule explicitly ties special payment to registration and use of the selected special-disease hospital. Emergency and clinically urgent decisions remain medical questions; preserve records and ask the agency later about any permitted reimbursement route.

The Beijing rule is up to two qualified institutions for each disease, not unrestricted use of two hospitals chosen only by reputation or convenience.

Track registration validity, cancellation and provider changes correctly

Beijing provides that outpatient special-disease registration takes effect on the filing date and generally continues until cancellation. This means the registration is not described as expiring automatically every calendar year. However, active insurance participation, annual settlement accounting, medicine rules, provider capability and a clinical treatment period can still change. Query the live record before a major treatment cycle.

To stop the registration or change a selected institution, Beijing instructs the participant to cancel through the original selected special-disease hospital. Ask the original institution what credential and form it requires, when cancellation becomes effective and how the new institution completes the replacement record. Do not simply start attending another hospital and assume the system will follow.

Keep the old and new effective dates. Avoid a gap during dialysis, antirejection treatment or another continuing therapy by coordinating administration early and following the medical team's continuity plan. Insurance staff can explain record filing; only the treating clinician can decide whether a change of provider, medicine or treatment timing is clinically safe.

Interpret “paid under inpatient standards” instead of quoting one flat percentage

Beijing states that registered outpatient special-disease expenses at the recorded special hospital are reimbursed under inpatient standards. That phrase does not mean every expense receives 85, 90 or another single percentage. The eligible base must first be disease-related and within the medical-insurance scope. The result then depends on employee or resident insurance, active employee or retiree status, hospital level, expense band, deductible already accumulated, annual maximum and any medicine-specific payment condition.

For employee insurance, the current general inpatient reference uses an RMB 1,300 first annual deductible and RMB 650 for later inpatient-standard settlement events, with an annual maximum of RMB 500,000. For active employees, the published basic percentages vary by hospital level and expense band: 85 to 90 percent in the lower band, 90 to 95 percent in the next band, 95 to 97 percent in the next, and 85 percent in the highest covered band. Retiree percentages are higher. The settlement system applies the participant's actual accumulated state.

For resident insurance, the published first inpatient deductibles for adults are RMB 300 at a level-one hospital, RMB 800 at level two and RMB 1,300 at level three, with half those amounts for students and children. General percentages are 80 percent, 78 percent and 75 percent respectively, with 78 percent at a district-owned level-three hospital, and the current annual maximum is RMB 250,000. These figures explain the architecture, not a guaranteed personal result.

Ask the settlement desk to show the eligible disease expense, deductible application, hospital-level rate, expense band and fund payment. Certain 2020 medicines have specific payment provisions; those cannot be generalised to all seventeen categories. Do not build a calculator that applies one percentage to the invoice total.

“Inpatient standards” is a calculation framework with several variables, not a universal Beijing outpatient special-disease reimbursement rate.

Separate the Beijing seventeen-category benefit from the national ten-category settlement channel

The national cross-province direct-settlement channel covers hypertension, diabetes, malignant-tumour outpatient radiotherapy and chemotherapy, uraemia or uremia dialysis, organ-transplant anti-rejection treatment, chronic obstructive pulmonary disease or COPD, rheumatoid arthritis, coronary heart disease, viral hepatitis and ankylosing spondylitis. Beijing's local list instead contains the seventeen categories above. The two sets overlap only in parts and use different administrative purposes.

Hypertension, diabetes, COPD, rheumatoid arthritis, coronary heart disease, viral hepatitis and ankylosing spondylitis are not added to Beijing's local seventeen merely because the national network can settle them for an incoming participant whose home insured place recognised the benefit. Conversely, Beijing categories such as multiple sclerosis, haemophilia or certain biologic and antifibrotic treatments are not automatically among the ten nationally connected categories.

The clearest overlaps include malignant-tumour outpatient treatment, renal dialysis and organ-transplant anti-rejection treatment, but names and codes still need to match. Do not infer interoperability from an English translation. Query the official platform and ask the provider whether it supports the exact home recognition. The 2024 Beijing notice named six institutions for the initial expansion rollout; that historical pilot list is not a current exhaustive provider directory and is not reproduced here.

For a Beijing participant going elsewhere, complete two administrative layers

A Beijing-insured participant seeking outpatient special-disease care outside the city should first complete general cross-province medical-treatment filing. Beijing's public workflow then requires the separate outpatient special-disease filing through the responsible district medical-insurance office, using the medical-insurance credential, diagnosis evidence and application. For each disease, the person generally chooses one or two institutions in the filed destination pooling area.

The destination institution must provide the relevant treatment and support cross-province settlement for the exact category. City-level general filing does not complete this institution-level disease layer. Query the provider and category in the official platform, then confirm with the hospital medical-insurance office. At registration and settlement, disclose the disease and use the credential linked to the active Beijing record.

Direct settlement uses the treatment-place catalogue, Beijing benefit policy and treatment-place administration. If the recognised Beijing category is outside the national ten or the destination provider cannot settle it, ask the Beijing district office whether full self-payment and manual reimbursement are allowed, what provider level is required and which originals must be returned. Preserve the invoice, itemised bill, prescription, diagnosis record, filing and failure evidence.

• Layer one: general cross-province filing
• Layer two: Beijing district outpatient special-disease filing
• Choose one or two qualified destination institutions per disease
• Confirm exact disease connectivity before treatment

For an incoming non-Beijing participant, use home recognition and Beijing provider capability

A participant insured in another province does not apply for Beijing local outpatient special-disease entitlement merely to use the national cross-province channel. The home insured place must first recognise the category and determine the deductible, payment percentage and ceiling. The participant completes the home filing and chooses a Beijing institution that supports the exact disease. Beijing applies the treatment-place catalogue and provider administration.

This is why an incoming participant with home-recognised hypertension or diabetes may settle at an enabled Beijing provider even though those conditions are not Beijing local outpatient special diseases. It is also why a Beijing diagnosis alone does not help an incoming participant whose home area has not granted recognition. National connectivity changes the payment route, not the home entitlement decision.

Ask the Beijing hospital whether the category, campus and service are enabled. General designated status or cross-province inpatient capability is not enough. Separate disease-related expenses at settlement. If a provider cannot support the category, contact the home insured place before accepting ordinary-outpatient settlement; full self-payment and manual reimbursement may be the permitted fallback.

Use pharmacy and long-prescription routes cautiously in Beijing

Beijing's general pharmacy guidance allows real-time reimbursement for an eligible external prescription from a Beijing designated medical institution when the participant uses a medical-insurance code or social-security card at a designated pharmacy. That is a general route. It does not prove that the transaction will retain outpatient special-disease inpatient-standard accounting. Ask the selected hospital whether disease-related medicine must settle through its special window or may use a specifically authorised external or double-channel pharmacy.

A general designated pharmacy is not automatically an outpatient special-disease pharmacy. Confirm the exact branch, medicine, electronic prescription, category and settlement capability. The pharmacy must also have stock and complete pharmacist review. Do not substitute or change treatment independently because one branch cannot dispense the medicine.

National long-term prescription standards generally provide four weeks, with a maximum of twelve weeks only for qualifying stable patients after assessment. The Beijing clinician determines whether the patient is stable, which monitoring is required and what duration is appropriate. A twelve-week maximum does not override medicine-specific, special-disease, prescription or pharmacy rules.

Ordinary designated-pharmacy reimbursement and Beijing outpatient special-disease settlement are not the same service.

Recheck 2026 medicine rules, annual accounting and the clinical boundary

Beijing's current drug implementation took effect on 1 January 2026 and updated medicines associated with eye injection, multiple sclerosis and asthma treatment. It also used the revised moderate-to-severe asthma biologic-treatment category. A transition for certain removed negotiated medicines ended on 30 June 2026, so it was no longer active at this guide's 16 July review. Check the current drug, indication, provider and payment restriction rather than relying on an earlier prescription.

Registration generally continues until cancellation, but deductibles and annual maximums follow the applicable insurance-year accounting. Drug catalogues and provider capability can change during a continuing registration. Before an expensive cycle or annual transition, confirm active participation, selected institutions, treatment scope, medicine eligibility and accumulated benefit. Keep settlement statements to understand how outpatient special-disease and inpatient-standard expenses have been aggregated.

Do not delay urgent care, dialysis, antirejection treatment or another medically necessary service solely to complete an administrative check. Follow the responsible clinician and medical team, preserve records and contact the district medical-insurance office as soon as practical. This guide does not diagnose a disease, decide whether a biologic, injection, dialysis modality or medicine is appropriate, or replace emergency instructions.